動態療法 (PDT) 市場規模、佔有率和成長分析（按作用機制、類別、治療方法、軟體、服務、應用可及性、應用和地區分類）— 2026-2033 年產業預測

全球動態療法 (PDT) 市場規模預計在 2024 年達到 49.3 億美元，從 2025 年的 59.3 億美元成長到 2033 年的 260.3 億美元，在預測期（2026-2033 年）以 20.3% 的複合年成長率。

全球動態療法市場持續發展，其驅動力在於人們對超越傳統療法的個人化、實證治療方法的需求日益成長。這種轉變源自於人們意識到，個人化治療方法而非僅依賴藥物，能夠提高患者參與度並改善治療效果。主要相關人員正攜手合作，將光治療性介入納入標準醫療實踐。隨著監管機構制定明確的市場核准路徑，支付方的興趣也日益濃厚，保險公司正在評估這些治療方法在慢性病和行為健康管理方面的有效性。市場也越來越重視臨床檢驗，數位醫療創新者與傳統醫療服務提供者之間的合作日益普遍。鑑於這些解決方案涉及敏感的健康資訊，數據隱私和安​​全問題至關重要，這也標誌著該市場正走向成熟。

全球動態療法市場促進因素

以患者為中心的醫療模式日益受到重視，這是推動全球動態療法 (PDT) 市場擴張的主要因素。人們越來越需要以個人化服務為優先的治療方案，而非僅依賴藥物治療。處方箋數位療法提供結構化的、實證的治療方案，可以根據個別需求進行調整。這一趨勢在慢性病和行為健康問題的管理中尤其重要，因為持續的參與和及時的回饋在有效的長期管理中發揮關鍵作用。隨著患者期望的不斷變化，客製化、技術主導的治療方案在醫療機構中越來越受歡迎。

全球動態療法市場限制因素

全球動態療法市場正在擴張，但醫療服務提供者和患者對其臨床益處和可及性的認知不足仍然是主要障礙。這種認知不足導致人們不願意採用該療法，造成處方率低落。此外，現有的訓練和教育課程往往不足，阻礙了其順利融入標準治療方案。關鍵相關人員的這種認知不足最終限制了市場的成長潛力，錯失了發展良機，並延緩了能夠改善患者照護和治療效果的創新解決方案的採用。

全球動態療法市場趨勢

全球動態療法市場正經歷藥物療法與數位治療方法融合的顯著趨勢。隨著製藥公司與數位醫療開發商加強合作，將動態療法與軟體解決方案相結合的創新產品應運而生。這種協同作用旨在透過同時改變患者行為和提高用藥依從性來最佳化治療效果。這種合作能夠實現即時依從性追蹤和寶貴的真實世界數據收集，最終改善治療效果並提升患者滿意度。數位療法與藥物療法的融合有望推動動態療法的發展，並帶來患者照護模式的變革性轉變。

目錄

介紹

• 調查目標
• 調查範圍
• 定義

調查方法

• 資訊收集
• 二手資料和一手資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分市場機會分析

市場動態與展望

• 市場規模
• 市場動態
  • 促進因素和機遇
  • 限制與挑戰
• 波特分析

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 關鍵投資機會
• 市場生態系統
• 市場吸引力指數（2025）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 定價分析
• 技術分析
• 案例研究
• 顧客購買行為分析

全球動態療法（PDT）市場規模（按機制分類）及複合年成長率（2026-2033）

• 輸入機制
• 輸出機制

全球動態療法（PDT）市場規模及按類別分類的複合年成長率（2026-2033）

• 輔助性治療
• 藥物替代療法

全球動態療法 (PDT) 市場規模及複合年成長率 (2026-2033)治療方法

• 門診治療
• 單藥治療

全球動態療法（PDT）市場規模（按軟體分類）及複合年成長率（2026-2033）

• 呼吸系統疾病軟體
• 心理健康軟體
• 鴉片類藥物使用疾患軟體
• 糖尿病軟體
• 其他

全球動態療法 (PDT) 市場規模及複合年成長率 (2026-2033) 依服務類型分類

• 行為微服務
• 醫療微服務

全球動態療法 (PDT) 市場規模（按應用普及程度和複合年成長率分類）（2026-2033 年）

• Android
• iOS
• Windows

全球動態療法（PDT）市場規模（按應用類型和複合年成長率分類）（2026-2033 年）

• 原生應用
• Web應用程式

全球動態療法（PDT）市場規模（按應用領域分類）及複合年成長率（2026-2033）

• 物質使用疾患（SUDs）
• 鴉片類藥物使用疾患（OUD）
• 注意力不足過動症（ADHD）
• 阿茲海默症
• 重度憂鬱症（MDD）
• 失眠
• 癲癇
• 運動障礙
• 多發性硬化症
• 偏頭痛
• 泛自閉症障礙
• 腫瘤學
• 發炎
• 呼吸系統
• 心血管系統
• 疼痛管理
• 代謝性疾病
• 其他

全球動態療法 (PDT) 市場規模及複合年成長率 (2026-2033 年)（按患者類型分類）

• 兒童
• 成人

全球動態療法（PDT）市場規模及複合年成長率（2026-2033）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 亞太其他地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業的市場定位（2025 年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市佔率分析（2025 年）
• 主要企業公司簡介
  • 公司詳情
  • 產品系列分析
  • 依業務板塊進行公司股票分析
  • 2023-2025年營收年比比較

主要企業簡介

• ResMed（US）
• SAMSUNGHEALTHCARE（South Korea）
• Novartis AG（Switzerland）
• Medtronic（Ireland）
• Omada Health, Inc.（US）
• GAIA AG（Germany）
• Welldoc's Bluestar（US）
• Better Therapeutics, LLC（US）
• BigHealth（US）
• Biofourmis（US）
• Click Therapeutics, Inc.（US）
• Happify, Inc.（US）
• Naturalcycles Nordic AB（Sweden）
• NuvoAir AB（Sweden）
• Sensyne Health plc.（UK）

結論與建議

Global Photodynamic Therapy Market size was valued at USD 4.93 Billion in 2024 and is projected to grow from USD 5.93 Billion in 2025 to USD 26.03 Billion by 2033, expanding at a CAGR of 20.3% during the forecast period (2026-2033).

The global photodynamic therapy market is evolving due to an increasing demand for personalized and evidence-based treatments that go beyond conventional options. This shift is fueled by the acknowledgment that customized therapies can enhance patient engagement and improve outcomes without solely depending on pharmacological solutions. Key stakeholders are collaborating to incorporate light-based therapeutic interventions into standard healthcare practices. As regulatory bodies establish clearer pathways for market approval, payer interest is rising, with insurers assessing the efficacy of these treatments for chronic and behavioral health management. The market also sees a focus on clinical validation, with partnerships between digital health innovators and traditional healthcare entities becoming prevalent. Concerns regarding data privacy and security are paramount as these solutions manage sensitive health information, indicating a maturation of the market.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Photodynamic Therapy market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Photodynamic Therapy Market Segments Analysis

Global Photodynamic Therapy (PDT) Market is segmented by Mechanism, Category, Treatment, Software, Services, App Accessibility, App Type, Application, Patients and region. Based on Mechanism, the market is segmented into Input Mechanisms and Output Mechanisms. Based on Category, the market is segmented into Medication Augmentation and Medication Replacement. Based on Treatment, the market is segmented into Outpatient Treatment and Monotherapy. Based on Software, the market is segmented into Software for Respiratory Conditions, Software for Mental Health, Software for Opioid Use Disorder, Software for Diabetes and Others. Based on Services, the market is segmented into Behavioral Microservices and Medical Microservices. Based on App Accessibility, the market is segmented into Android, iOS and Windows. Based on App Type, the market is segmented into Native Apps and Web Apps. Based on Application, the market is segmented into Substance Use Disorder (SUD), Opioid Use Disorder (OUD), Attention Deficit/Hyperactivity Disorder (ADHD), Alzheimer's Disease, Major Depressive Disorder (MDD), Insomnia, Epilepsy, Movement Disorder, Multiple Sclerosis, Migraine, Autism Spectrum Disorder, Oncology, Inflammation, Respiratory, Cardiovascular, Pain Management, Metabolic Conditions and Others. Based on Patients, the market is segmented into Children and Adults. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Photodynamic Therapy Market

The increasing focus on patient-centered care has significantly contributed to the expansion of the global Photodynamic Therapy (PDT) market. There is a growing demand for therapeutic solutions that prioritize personalized support over dependence solely on medication. Prescription digital therapeutics offer structured and evidence-based programs that are adaptable to individual requirements. This trend is especially pertinent for managing chronic and behavioral health issues, where ongoing engagement and timely feedback play crucial roles in effective long-term management. As patient expectations evolve, the attractiveness of customized, technology-driven therapies continues to gain momentum within the healthcare landscape.

Restraints in the Global Photodynamic Therapy Market

Although the global Photodynamic Therapy market is expanding, a significant barrier is the prevalent lack of awareness among healthcare providers and patients regarding its clinical benefits and accessibility. This unfamiliarity fosters reluctance to adopt the treatment, resulting in diminished prescription rates. Furthermore, existing training and educational initiatives are often inadequate, hindering the seamless incorporation of these therapies into standard treatment practices. The limited understanding among key stakeholders ultimately restricts the market's growth potential, leaving opportunities unexploited and delaying the integration of innovative solutions that could enhance patient care and outcomes.

Market Trends of the Global Photodynamic Therapy Market

The Global Photodynamic Therapy market is witnessing a significant trend towards the integration of drug-digital combination therapies. As pharmaceutical companies increasingly collaborate with digital health developers, they are creating innovative offerings that merge photodynamic treatments with software solutions. This synergy aims to optimize therapeutic outcomes by simultaneously influencing patient behaviors and enhancing medication adherence. Such collaborations enable real-time adherence tracking and the collection of valuable real-world data, ultimately leading to improved treatment efficacy and patient satisfaction. This convergence of digital and pharmacological strategies is poised to drive advancements in photodynamic therapies, reflecting a transformative shift in patient care models.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technology Analysis
• Case Studies
• Customer Buying Behavior Analysis

Global Photodynamic Therapy (PDT) Market Size by Mechanism & CAGR (2026-2033)

• Market Overview
• Input Mechanisms
• Output Mechanisms

Global Photodynamic Therapy (PDT) Market Size by Category & CAGR (2026-2033)

• Market Overview
• Medication Augmentation
• Medication Replacement

Global Photodynamic Therapy (PDT) Market Size by Treatment & CAGR (2026-2033)

• Market Overview
• Outpatient Treatment
• Monotherapy

Global Photodynamic Therapy (PDT) Market Size by Software & CAGR (2026-2033)

• Market Overview
• Software for Respiratory Conditions
• Software for Mental Health
• Software for Opioid Use Disorder
• Software for Diabetes
• Others

Global Photodynamic Therapy (PDT) Market Size by Services & CAGR (2026-2033)

• Market Overview
• Behavioral Microservices
• Medical Microservices

Global Photodynamic Therapy (PDT) Market Size by App Accessibility & CAGR (2026-2033)

• Market Overview
• Android
• iOS
• Windows

Global Photodynamic Therapy (PDT) Market Size by App Type & CAGR (2026-2033)

• Market Overview
• Native Apps
• Web Apps

Global Photodynamic Therapy (PDT) Market Size by Application & CAGR (2026-2033)

• Market Overview
• Substance Use Disorder (SUD)
• Opioid Use Disorder (OUD)
• Attention Deficit/Hyperactivity Disorder (ADHD)
• Alzheimer's Disease
• Major Depressive Disorder (MDD)
• Insomnia
• Epilepsy
• Movement Disorder
• Multiple Sclerosis
• Migraine
• Autism Spectrum Disorder
• Oncology
• Inflammation
• Respiratory
• Cardiovascular
• Pain Management
• Metabolic Conditions
• Others

Global Photodynamic Therapy (PDT) Market Size by Patients & CAGR (2026-2033)

• Market Overview
• Children
• Adults

Global Photodynamic Therapy (PDT) Market Size & CAGR (2026-2033)

• North America (Mechanism, Category, Treatment, Software, Services, App Accessibility, App Type, Application, Patients)
  • US
  • Canada
• Europe (Mechanism, Category, Treatment, Software, Services, App Accessibility, App Type, Application, Patients)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Mechanism, Category, Treatment, Software, Services, App Accessibility, App Type, Application, Patients)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Mechanism, Category, Treatment, Software, Services, App Accessibility, App Type, Application, Patients)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Mechanism, Category, Treatment, Software, Services, App Accessibility, App Type, Application, Patients)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• ResMed (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SAMSUNGHEALTHCARE (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novartis AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Omada Health, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GAIA AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Welldoc's Bluestar (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Better Therapeutics, LLC (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BigHealth (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biofourmis (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Click Therapeutics, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Happify, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Naturalcycles Nordic AB (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NuvoAir AB (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sensyne Health plc. (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations